Long Wei, Zhang Shi-chang, Wen Lu, Mu Lei, Yang Fan, Chen Gang
School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.
School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.
J Ethnopharmacol. 2014 Oct 28;156:199-208. doi: 10.1016/j.jep.2014.08.041. Epub 2014 Sep 16.
Salvia miltiorrhiza Bunge (Labiatae sp. plant, Chinese name Danshen) and Panax notoginseng (Burk.) F. H. Chen (Araliaceae plant, Chinese name Sanqi) have a long history in treating coronary heart disease, cerebrovascular disease and inner ear disorders in traditional Chinese medicine. To provide a rational basis for the use of these herbs in clinical practice, we investigated the in vivo distribution and pharmacokinetics of marker agents in Danshen and Sanqi via intravenous and inner ear administration and explored the potential interactions of these agents in compound prescription.
Guinea pigs were given Danshen extracts (salvianolic acid B, tanshinone IIA), Sanqi extracts (Panax notoginseng saponins) and combination of the two extracts via intravenous and intratympanic administration (IT). Samples from the brain, inner ear perilymph (PL), cerebrospinal fluid (CSF) and plasma were collected at different time points. The concentration of salvianolic acid B (Sal B), tanshinone IIA (Ts IIA), notoginsenoside R₁ (R₁), ginsenoside Rg₁ (Rg₁) and ginsenoside Rb₁ (Rb₁) was determined by high-performance liquid chromatography coupled with a diode array detector (DAD). Pharmacokinetic parameters were estimated using non-compartmental methods.
Local drug application via inner ear greatly improved drug distribution within the PL, CSF and brain tissues compared with intravenous administration (IV). The values of Cmax and AUC(0-t) after IT were significantly higher than IV. In comparison with IT of Danshen and Sanqi alone, the pharmacokinetic parameters for R₁, Rg₁, Rb₁, Sal B and Ts IIA were markedly different in the compound prescription. The compound compatibility enhanced the transport of Danshen components into the brain through the inner ear and apparently prolonged the retention time in CSF while decreasing the distribution of Sanqi components in the inner ear and brain.
The results indicated that local drug application to the inner ear was a more effective delivery route than systemic administration. Co-administration of Danshen and Sanqi could cause significant pharmacokinetic herb-herb interactions in guinea pigs. The multiple active components via inner ear administration might be promising candidates for the treatment of inner ear and brain diseases.
丹参(唇形科植物,中药名丹参)和三七(五加科植物,中药名三七)在中医治疗冠心病、脑血管疾病及内耳疾病方面有着悠久的历史。为了为这些草药在临床实践中的应用提供合理依据,我们通过静脉注射和内耳给药研究了丹参和三七中标记物的体内分布及药代动力学,并探讨了这些药物在复方中的潜在相互作用。
通过静脉注射和鼓室内给药(IT),给豚鼠分别注射丹参提取物(丹酚酸B、丹参酮IIA)、三七提取物(三七皂苷)以及两种提取物的组合。在不同时间点采集脑、内耳外淋巴(PL)、脑脊液(CSF)和血浆样本。采用高效液相色谱 - 二极管阵列检测器(DAD)测定丹酚酸B(Sal B)、丹参酮IIA(Ts IIA)、三七皂苷R₁(R₁)、人参皂苷Rg₁(Rg₁)和人参皂苷Rb₁(Rb₁)的浓度。使用非房室模型方法估算药代动力学参数。
与静脉注射(IV)相比,通过内耳局部给药极大地改善了药物在PL、CSF和脑组织中的分布。IT给药后的Cmax和AUC(0 - t)值显著高于IV。与单独的丹参和三七IT给药相比,复方中R₁、Rg₁、Rb₁、Sal B和Ts IIA的药代动力学参数有显著差异。复方配伍增强了丹参成分通过内耳向脑内的转运,并明显延长了在CSF中的滞留时间,同时减少了三七成分在内耳和脑内的分布。
结果表明,内耳局部给药是一种比全身给药更有效的给药途径。丹参和三七联合给药可在豚鼠体内引起显著的药代动力学草药 - 草药相互作用。通过内耳给药的多种活性成分可能是治疗内耳和脑部疾病的有前途的候选药物。